Lauciello Leonardo, Lack Gabriela, Scapozza Leonardo, Perozzo Remo
Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel-Servet 1, CH-1211 Geneva 4, Switzerland.
Biochem Biophys Rep. 2016 Oct 6;8:310-317. doi: 10.1016/j.bbrep.2016.09.017. eCollection 2016 Dec.
The natural substrates of the enzymes involved in type-II fatty acid biosynthesis (FAS-II) are acylated acyl carrier proteins (acyl-ACPs). The state of the art method to produce acyl-ACPs involves the transfer of a phosphopantetheine moiety from CoA to apo-ACP by holo-ACP synthase (EcACPS), yielding holo-ACP which subsequently becomes thioesterified with free fatty acids by the acyl-ACP synthase (EcAAS). Alternatively, acyl-ACPs can be synthesized by direct transfer of acylated phosphopantetheine moieties from acyl-CoA to apo-ACP by means of EcACPS. The need for native substrates to characterize the FAS-II enzymes of prompted us to investigate the potential and limit of the two methods to efficiently acylate ACP (PfACP) with respect to chain length and β-modification and in preparative amounts. The EcAAS activity is found to be independent from the oxidation state at the β-position and accepts fatty acids as substrates with chain lengths starting from C8 to C20, whereas EcACPS accepts very efficiently acyl-CoAs with chain lengths up to C16, and with decreasing activity also longer chains (C18 to C20). Methods were developed to synthesize and purify preparative amounts of high quality natural substrates that are fully functional for the enzymes of the FAS-II system.
参与II型脂肪酸生物合成(FAS-II)的酶的天然底物是酰化酰基载体蛋白(酰基-ACP)。生产酰基-ACP的现有技术方法包括通过全酶-ACP合酶(EcACPS)将磷酸泛酰巯基乙胺部分从辅酶A转移至脱辅基-ACP,生成全酶-ACP,随后其通过酰基-ACP合酶(EcAAS)与游离脂肪酸硫酯化。或者,酰基-ACP可以通过EcACPS将酰化的磷酸泛酰巯基乙胺部分从酰基辅酶A直接转移至脱辅基-ACP来合成。由于需要天然底物来表征FAS-II酶,这促使我们研究这两种方法在以制备量就链长和β-修饰有效酰化ACP(PfACP)方面的潜力和局限性。发现EcAAS活性与β位的氧化态无关,接受链长从C8到C20的脂肪酸作为底物,而EcACPS非常有效地接受链长高达C16的酰基辅酶A,对于更长的链(C18至C20)活性逐渐降低。已开发出合成和纯化制备量的高质量天然底物的方法,这些底物对FAS-II系统的酶具有完全功能性。